PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
14 hedge funds and large institutions have $10.5M invested in PLx Pharma Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 12 closing their positions.
1,422% more capital invested
Capital invested by funds: $690K → $10.5M (+$9.81M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
26% less funds holding
Funds holding: 19 → 14 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$7.69M |
| 2 |
6CM
683 Capital Management
New York
|
+$2.13M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.68M |
| 4 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
+$459K |
| 5 |
HWA
Heritage Way Advisors
Rockford,
Illinois
|
+$235K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$150K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$56K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$42K |
| 4 |
MC
Middleton & Co
Boston,
Massachusetts
|
-$21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20K |
PLXP Hedge Fund Activity: Q2 2017 in Review
14 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2017, worth a combined $10.5M — up 1,422% from $690K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PLXP and 7 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Park West Asset Management, adding an estimated $7.69M. The largest seller was Vanguard Group, exiting entirely with an estimated $150K sold.
- 14 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2017, down from 19 in Q1 2017.
- Funds reported $10.5M of PLx Pharma Inc. Common Stock stock for Q2 2017, up 1,422% quarter-over-quarter.
- 7 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2017 and 12 closed out, a net change of -5 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2017 was Park West Asset Management, an estimated $7.69M added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2017 was Vanguard Group, an estimated $150K sold.
Based on aggregated 13F filings for Q2 2017.